Why did Nvidia reach $4 trillion market cap?
How are Trump's tariffs impacting copper prices?
What led to Linda Yaccarino stepping down at X?
Why was the FTC 'click-to-cancel' rule blocked?
How will rising student loan payments affect borrowers?
What caused Revolut's valuation to jump to $65B?
How is AI reshaping advertising at WPP?
Shares Skyrocket On Promising Kidney Disease Drug Trial Results
benzinga.com/trading-ideas/movers/25/07/46323832/prokidney-prok-shares-skyrocket-on-promising-kidney-disease-drug-trial-results
ProKidney Ord Shs Class A (NASDAQ:PROK) shares are trading sharply higher Wednesday morning, following a marked surge on Tuesday driven by positive clinical trial data for its chronic kidney disease (CKD) treatment.
The company’s shares are gaining again Wednesday as investors continue…
This story appeared on benzinga.com, 2025-07-09 15:41:56.